Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A small randomized trial of vitamin D plus vaginal probiotics increased clinical pregnancy and showed a numerically higher live-birth outcomes, though precision was limited.

Source: Higher-certainty interventional evidence from randomized controlled trials. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis not reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level

Source: Article title.

When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level

Systematic review · Frontiers in Endocrinology · 2026

Original publication title

Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level

Maria Jimena Barroso Alverde; Sion Yu; Daniel Pascal Pontón; Denise Niza Benardete Harari; José Elias Tesone Lasman

Copyright © 2026 Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasman.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

The aim of this study was to synthesize evidence on interventions that restore or improve fertility in women aged 30 to 42 years, grouped by etiology.

Source: Objective

Abstract: Importance

Female infertility affects approximately one in six couples worldwide and disproportionately impacts women aged 30 to 42 years, yet evidence on which interventions improve clinically meaningful outcomes (live birth and safety) is heterogeneous.

Source: Importance

Abstract: Evidence review

We conducted a PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-compliant systematic review (PROSPERO CRD420251109428). PubMed and Scopus were searched for English/Spanish studies (1 January 2020 to 31 July 2025). Eligible designs were randomized trials and non-randomized interventional and observational studies. We aligned outcomes to the infertility core outcome set, prioritizing live birth per woman, then ongoing/clinical pregnancy and prespecified safety endpoints. Risk of bias used RoB 2 [randomized controlled trials (RCTs)], ROBINS-I (non-randomized), and JBI (observational). When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.

Source: Evidence review

Abstract: Conclusions and relevance

For women aged 30 to 42 years, established hormonal and ART strategies improve pregnancy outcomes; however, certainty for live birth and safety remains limited. Clinical care should prioritize standard therapies and shared decision-making, acknowledging evidence gaps. Future trials must center on live birth, adopt standardized core outcomes, and consistently report maternal: neonatal safety.

Source: Conclusions and relevance

Abstract: Systematic review registration

Abstract: Findings

A total of 21 studies met inclusion criteria for synthesis, and two additional randomized protocols were summarized narratively (23 records tracked overall). Interventions spanned hormonal therapies, assisted reproductive technologies (ART) strategies, surgical procedures, lifestyle and psychosocial programs, and investigational adjuncts. Across etiologies, several interventions were associated with improved pregnancy-related outcomes: such as myo-inositol, clomiphene with sildenafil, selected luteal support regimens, structured stress management, and specific ART strategies: whereas live-birth effects were supported by only moderate-certainty evidence, limited by small samples, heterogeneity, and indirectness.

Diagnostic and prognostic approaches (e.g., serum progesterone profiling, BAP-EB receptivity assay, and endometrial T-bet/GATA3 ratio) showed predictive value but no therapeutic effect. Safety reporting was limited; few studies reported ovarian hyperstimulation syndrome, multiple gestation, or neonatal outcomes, and patient-reported outcomes were seldom assessed.

Source: Findings
Authors’ abstract

Importance

Female infertility affects approximately one in six couples worldwide and disproportionately impacts women aged 30 to 42 years, yet evidence on which interventions improve clinically meaningful outcomes (live birth and safety) is heterogeneous.

Objective

The aim of this study was to synthesize evidence on interventions that restore or improve fertility in women aged 30 to 42 years, grouped by etiology.

Evidence review

We conducted a PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-compliant systematic review (PROSPERO CRD420251109428). PubMed and Scopus were searched for English/Spanish studies (1 January 2020 to 31 July 2025). Eligible designs were randomized trials and non-randomized interventional and observational studies. We aligned outcomes to the infertility core outcome set, prioritizing live birth per woman, then ongoing/clinical pregnancy and prespecified safety endpoints. Risk of bias used RoB 2 [randomized controlled trials (RCTs)], ROBINS-I (non-randomized), and JBI (observational). When pooling was not feasible, we applied SwiM (Synthesis Without Meta-analysis) and summarized by etiology and intervention class.

Findings

A total of 21 studies met inclusion criteria for synthesis, and two additional randomized protocols were summarized narratively (23 records tracked overall). Interventions spanned hormonal therapies, assisted reproductive technologies (ART) strategies, surgical procedures, lifestyle and psychosocial programs, and investigational adjuncts. Across etiologies, several interventions were associated with improved pregnancy-related outcomes: such as myo-inositol, clomiphene with sildenafil, selected luteal support regimens, structured stress management, and specific ART strategies: whereas live-birth effects were supported by only moderate-certainty evidence, limited by small samples, heterogeneity, and indirectness.

Diagnostic and prognostic approaches (e.g., serum progesterone profiling, BAP-EB receptivity assay, and endometrial T-bet/GATA3 ratio) showed predictive value but no therapeutic effect. Safety reporting was limited; few studies reported ovarian hyperstimulation syndrome, multiple gestation, or neonatal outcomes, and patient-reported outcomes were seldom assessed.

Conclusions and relevance

For women aged 30 to 42 years, established hormonal and ART strategies improve pregnancy outcomes; however, certainty for live birth and safety remains limited. Clinical care should prioritize standard therapies and shared decision-making, acknowledging evidence gaps. Future trials must center on live birth, adopt standardized core outcomes, and consistently report maternal: neonatal safety.

Systematic review registration

https://www.crd.york.ac.uk/prospero/, identifier CRD420251109428.

Publication and source details

Original title: Evidence-based interventions to restore or improve female fertility in women aged 30 to 42 years: a systematic review by etiology and evidence level

Maria Jimena Barroso Alverde; Sion Yu; Daniel Pascal Pontón; Denise Niza Benardete Harari; José Elias Tesone Lasman

Frontiers in Endocrinology · 2026

* Correspondence: Maria Jimena Barroso Alverde, jimenabarroso1@gmail.comCopyright © 2026 Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasman.2026Barroso Alverde, Yu, Pascal Pontón, Benardete Harari and Tesone Lasmanhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:20:21.154534+00:00

DOI: 10.3389/fendo.2026.1741198 · PMC13286824